InvestorsHub Logo
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

Re: i_invest_utrade post# 10474

Friday, 12/14/2007 11:50:43 PM

Friday, December 14, 2007 11:50:43 PM

Post# of 30387
I respectfully disagree. If Dr Moro had not attended any of the scientific meetings he would have no one to collaborate with (meaning no samples to test), no contract with Abbott, and no one in discussions for potential licensing. Their method of buying publicity has only caused dilution, liquidation at any price, and has caused the share price to be where it is today. Reread the interview with Dr Moro and Erthang. Dr Moro's quoted as saying that after the announcement of the Abbott deal we were well over 2 dollars and now we are closer than ever to commercialization and the share price is significantly lower and he was baffled by this. He is a doctor and so is Wittenberg and they have failed to see the damage of giving away shares which should have had a lockup period of several years. The slap in the face is the same people he entrusted to promote the company to elevate the share price were exactly the one's that have caused the share price to tumble to these levels. They never should have issued unrestricted shares on a stock that has the ability to move in any direction by more than 10% on a few thousand shares. This is not a liquid stock.
You seem to have forgotten Dr Moro has moved on from diagnostics, because the test IS ready.
It is an objective view of Dr Wittenberg's performance and his report card when the share price has declined significantly. Would you give your money to a money manager and 2 1/2 years later see he lost 75% of your hard hard earned money. Would you allow him to continue to manage your money? That's what you are saying by being complacent in regards to his performance. If he isn't ultimately responsible, who is?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.